Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Christopher DeSouza

Concepts (402)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endothelium, Vascular
46
2025
903
9.290
 Why?
Cell-Derived Microparticles
15
2025
68
8.770
 Why?
Vasodilation
30
2025
476
6.100
 Why?
Endothelin-1
17
2025
179
5.640
 Why?
Endothelial Cells
16
2025
749
4.210
 Why?
Vasoconstriction
14
2025
199
4.080
 Why?
Fibrinolysis
16
2023
137
3.410
 Why?
Human Umbilical Vein Endothelial Cells
8
2025
102
3.090
 Why?
Tissue Plasminogen Activator
18
2024
222
2.990
 Why?
Nitric Oxide
14
2024
895
2.820
 Why?
Vasodilator Agents
22
2025
326
2.760
 Why?
Hypertension
14
2023
1243
2.730
 Why?
Forearm
18
2021
117
2.660
 Why?
Sleep Deprivation
6
2021
171
2.660
 Why?
Obesity
20
2025
2882
2.570
 Why?
Aging
39
2011
1778
2.210
 Why?
Overweight
9
2018
531
2.180
 Why?
MicroRNAs
7
2025
679
2.170
 Why?
Nitric Oxide Synthase Type III
8
2024
203
2.090
 Why?
Spinal Cord Injuries
4
2023
194
1.990
 Why?
Exercise
34
2024
1928
1.870
 Why?
Acetylcholine
17
2025
183
1.820
 Why?
Middle Aged
111
2025
31136
1.730
 Why?
Regional Blood Flow
24
2025
463
1.720
 Why?
Prehypertension
5
2015
27
1.720
 Why?
Vasomotor System
2
2025
44
1.630
 Why?
Cardiovascular Diseases
11
2021
2006
1.580
 Why?
Apoptosis
15
2024
2492
1.570
 Why?
Blood Pressure
20
2021
1736
1.560
 Why?
HIV Envelope Protein gp120
3
2019
57
1.540
 Why?
Sleep
5
2021
687
1.500
 Why?
Polycythemia
2
2021
22
1.440
 Why?
Stem Cells
8
2012
575
1.420
 Why?
Postmenopause
18
2023
349
1.280
 Why?
NG-Nitroarginine Methyl Ester
3
2024
48
1.250
 Why?
Nitroprusside
16
2021
67
1.240
 Why?
Enzyme Inhibitors
6
2024
827
1.220
 Why?
tat Gene Products, Human Immunodeficiency Virus
2
2019
23
1.210
 Why?
Male
92
2025
63670
1.190
 Why?
Circulating MicroRNA
2
2019
25
1.180
 Why?
Metabolic Syndrome
4
2016
340
1.170
 Why?
C-Reactive Protein
7
2015
400
1.170
 Why?
Nebivolol
2
2017
9
1.090
 Why?
Cell Movement
8
2014
948
1.080
 Why?
Atherosclerosis
2
2023
402
1.080
 Why?
Humans
137
2025
129625
1.060
 Why?
Platelet Endothelial Cell Adhesion Molecule-1
3
2011
55
1.030
 Why?
Peptides, Cyclic
7
2013
256
1.030
 Why?
Caspase 3
5
2017
245
1.010
 Why?
Inflammation Mediators
5
2024
505
0.970
 Why?
Adult
68
2023
35599
0.920
 Why?
Vasoconstrictor Agents
6
2023
127
0.910
 Why?
Female
83
2025
68734
0.910
 Why?
Work-Life Balance
1
2024
19
0.890
 Why?
Fibrin Fibrinogen Degradation Products
2
2023
82
0.870
 Why?
Physical Endurance
16
2024
262
0.830
 Why?
Goals
1
2024
159
0.810
 Why?
Aged
64
2021
22061
0.810
 Why?
Dietary Fats
2
2015
301
0.800
 Why?
Blood Coagulation
2
2021
239
0.760
 Why?
Cells, Cultured
9
2024
4084
0.760
 Why?
Estrogen Replacement Therapy
9
2003
137
0.720
 Why?
Vascular Diseases
1
2023
240
0.710
 Why?
Altitude
3
2021
462
0.690
 Why?
Case-Control Studies
11
2021
3378
0.650
 Why?
Physical Fitness
12
2005
203
0.650
 Why?
Oxidative Stress
7
2021
1266
0.650
 Why?
Acclimatization
1
2021
165
0.640
 Why?
Cross-Sectional Studies
23
2023
5075
0.640
 Why?
Hemodynamics
8
2021
1090
0.630
 Why?
Ascorbic Acid
3
2021
120
0.630
 Why?
Telomere
3
2010
233
0.610
 Why?
T-Lymphocyte Subsets
2
2011
412
0.600
 Why?
Endothelium
3
2020
121
0.590
 Why?
Dose-Response Relationship, Drug
9
2017
2011
0.590
 Why?
Biomarkers
12
2025
3968
0.590
 Why?
Hematopoietic Stem Cells
2
2011
382
0.570
 Why?
Metoprolol
1
2017
39
0.570
 Why?
HIV
1
2019
227
0.560
 Why?
Blood Glucose
7
2019
2100
0.560
 Why?
Plethysmography
5
2017
106
0.560
 Why?
Hyperglycemia
2
2018
327
0.550
 Why?
Bradykinin
8
2015
45
0.540
 Why?
Stress, Physiological
2
2017
414
0.530
 Why?
Receptor, Endothelin A
2
2014
63
0.530
 Why?
HIV Infections
4
2019
2730
0.530
 Why?
Plasminogen Activator Inhibitor 1
7
2023
84
0.520
 Why?
Cellular Senescence
1
2018
181
0.510
 Why?
Cytokines
4
2020
2021
0.510
 Why?
Body Mass Index
15
2017
2274
0.510
 Why?
Nitric Oxide Synthase
4
2017
237
0.490
 Why?
Interleukin-6
6
2025
723
0.490
 Why?
Gender Identity
2
2006
117
0.470
 Why?
Blood Pressure Determination
2
2016
148
0.470
 Why?
Diet, High-Fat
2
2018
239
0.460
 Why?
Endothelial Progenitor Cells
1
2014
20
0.430
 Why?
Blood Platelets
1
2017
382
0.430
 Why?
Interleukin-8
3
2025
264
0.430
 Why?
Glucose
2
2017
1002
0.420
 Why?
Analysis of Variance
7
2016
1293
0.420
 Why?
Adiposity
3
2016
504
0.410
 Why?
Infusions, Intra-Arterial
5
2013
53
0.410
 Why?
Colony-Forming Units Assay
6
2014
90
0.400
 Why?
Transcription Factor RelA
2
2024
84
0.400
 Why?
Blood Vessels
1
2014
187
0.390
 Why?
Inflammation
5
2025
2750
0.390
 Why?
Endothelin A Receptor Antagonists
4
2014
24
0.390
 Why?
Arteries
7
2018
265
0.390
 Why?
Alkalosis, Respiratory
2
2023
2
0.390
 Why?
Anti-HIV Agents
1
2019
757
0.390
 Why?
Oxygen Consumption
12
2024
672
0.380
 Why?
Coronary Disease
3
2007
385
0.380
 Why?
Body Composition
14
2009
649
0.380
 Why?
T-Lymphocytes
2
2010
1936
0.370
 Why?
Glucose Intolerance
1
2013
142
0.370
 Why?
Time Factors
10
2021
6555
0.370
 Why?
Muscle, Smooth, Vascular
5
2010
444
0.360
 Why?
NF-kappa B
3
2025
665
0.360
 Why?
Fatty Acids
1
2014
427
0.360
 Why?
Abdominal Fat
1
2011
40
0.360
 Why?
Young Adult
11
2023
12455
0.350
 Why?
Antigens, CD34
1
2011
88
0.350
 Why?
Risk Factors
14
2018
9786
0.350
 Why?
Muscle Tonus
2
2010
21
0.350
 Why?
HIV Protease Inhibitors
1
2011
68
0.350
 Why?
HIV-1
2
2019
838
0.330
 Why?
Dyslipidemias
1
2012
177
0.330
 Why?
Chemotaxis
1
2010
129
0.330
 Why?
Health
1
2010
75
0.330
 Why?
Cholesterol, LDL
1
2012
358
0.330
 Why?
Heart Failure
1
2023
2133
0.330
 Why?
Postprandial Period
3
2019
104
0.330
 Why?
Sleep Wake Disorders
1
2013
252
0.320
 Why?
Disease
1
2010
95
0.320
 Why?
Feeding Behavior
1
2015
622
0.320
 Why?
Flow Cytometry
4
2019
1159
0.310
 Why?
Vascular Endothelial Growth Factor A
4
2014
530
0.310
 Why?
Muscarinic Agonists
1
2008
16
0.290
 Why?
Phosphorylation
2
2024
1713
0.290
 Why?
Fasting
4
2019
267
0.280
 Why?
Reference Values
7
2016
794
0.280
 Why?
Exercise Therapy
4
2017
412
0.270
 Why?
omega-N-Methylarginine
3
2015
26
0.270
 Why?
Reactive Oxygen Species
2
2021
593
0.270
 Why?
Endothelin Receptor Antagonists
4
2011
62
0.270
 Why?
Adult Stem Cells
1
2006
39
0.260
 Why?
Dinucleotide Repeats
1
2005
4
0.250
 Why?
Epigenesis, Genetic
1
2010
617
0.240
 Why?
Double-Blind Method
5
2021
1875
0.240
 Why?
Hyperthermia, Induced
2
2023
109
0.240
 Why?
Myocardial Ischemia
1
2006
259
0.230
 Why?
Walking
5
2018
500
0.230
 Why?
Adipose Tissue
6
2005
591
0.230
 Why?
Premenopause
5
2002
120
0.230
 Why?
Estrogen Receptor alpha
1
2005
130
0.220
 Why?
Physiology
1
2024
14
0.220
 Why?
Signal Transduction
5
2025
4931
0.220
 Why?
Blood Flow Velocity
3
2012
406
0.220
 Why?
Age Factors
8
2010
3152
0.220
 Why?
Endothelin B Receptor Antagonists
2
2014
11
0.220
 Why?
Quadriplegia
1
2023
12
0.220
 Why?
Antihypertensive Agents
4
2013
485
0.220
 Why?
Carotid Arteries
5
2003
196
0.210
 Why?
Hypertrophy
2
2023
122
0.210
 Why?
von Willebrand Factor
1
2023
71
0.210
 Why?
Actinin
1
2023
13
0.210
 Why?
Thrombophilia
1
2023
81
0.210
 Why?
Troponin T
1
2023
57
0.200
 Why?
Running
5
2000
223
0.200
 Why?
Contraceptives, Oral
1
2002
39
0.200
 Why?
Receptor, Endothelin B
2
2014
50
0.190
 Why?
Career Choice
1
2024
207
0.190
 Why?
Vaping
1
2023
54
0.190
 Why?
Electronic Nicotine Delivery Systems
1
2023
89
0.190
 Why?
Sex Characteristics
4
2017
736
0.180
 Why?
Breathing Exercises
1
2021
20
0.180
 Why?
Colorado
6
2024
4404
0.180
 Why?
Estradiol
1
2025
494
0.180
 Why?
Inhalation
1
2021
28
0.180
 Why?
Respiratory Muscles
1
2021
32
0.180
 Why?
Diet, Sodium-Restricted
1
2001
34
0.180
 Why?
South America
1
2021
58
0.180
 Why?
Peru
1
2021
53
0.180
 Why?
Diet, Carbohydrate-Restricted
2
2018
32
0.180
 Why?
Lymphocyte Count
2
2011
148
0.180
 Why?
Endothelins
1
2021
62
0.170
 Why?
Healthy Lifestyle
1
2021
32
0.170
 Why?
Drug Administration Schedule
2
2016
767
0.170
 Why?
Tumor Necrosis Factor-alpha
3
2015
1202
0.170
 Why?
Transforming Growth Factor beta
1
2023
460
0.170
 Why?
Fibrosis
1
2023
526
0.170
 Why?
Cytochromes c
2
2010
59
0.170
 Why?
Diabetes Mellitus, Type 2
3
2019
2442
0.170
 Why?
Chemokine CXCL12
2
2010
79
0.170
 Why?
Fibrinogen
2
1998
163
0.170
 Why?
Piperidines
2
2013
201
0.160
 Why?
Oligopeptides
2
2013
258
0.160
 Why?
Fever
2
2020
299
0.160
 Why?
Physical Exertion
2
1998
205
0.160
 Why?
Cell Proliferation
1
2006
2373
0.160
 Why?
Insulin Glargine
1
2019
81
0.160
 Why?
Risk Reduction Behavior
1
2021
209
0.160
 Why?
E-Selectin
1
2018
55
0.150
 Why?
Hemoglobins
1
2021
339
0.150
 Why?
HIV Antibodies
1
2019
57
0.150
 Why?
Infusions, Intravenous
2
2011
399
0.150
 Why?
Myocytes, Cardiac
1
2023
499
0.150
 Why?
Brachial Artery
3
2017
192
0.150
 Why?
Telomerase
2
2011
234
0.150
 Why?
Phenotype
2
2021
3075
0.150
 Why?
Heat-Shock Response
1
2018
72
0.150
 Why?
Follow-Up Studies
3
2017
4894
0.150
 Why?
Antioxidants
1
2021
558
0.150
 Why?
Biomedical Research
1
2024
640
0.140
 Why?
Adrenergic beta-1 Receptor Antagonists
1
2017
11
0.140
 Why?
Vascular Cell Adhesion Molecule-1
1
1997
37
0.140
 Why?
Pilot Projects
1
2023
1592
0.140
 Why?
Treatment Outcome
5
2021
10219
0.140
 Why?
Lipids
3
2009
627
0.140
 Why?
Myocardial Infarction
1
2005
1021
0.140
 Why?
Dietary Carbohydrates
1
2018
151
0.140
 Why?
Intercellular Adhesion Molecule-1
1
1997
135
0.140
 Why?
Heart
1
2021
641
0.140
 Why?
Prognosis
3
2018
3774
0.130
 Why?
Infusions, Intraosseous
1
2016
17
0.130
 Why?
Anthropometry
2
2011
204
0.130
 Why?
Insulin
2
2005
2326
0.120
 Why?
Baroreflex
3
2001
53
0.120
 Why?
Enzyme Activation
1
2017
813
0.120
 Why?
Triglycerides
3
2005
528
0.120
 Why?
Substance P
2
2008
43
0.120
 Why?
Isoproterenol
2
2008
116
0.120
 Why?
Down-Regulation
1
2017
636
0.120
 Why?
Blood Circulation
1
2015
41
0.120
 Why?
Insulin Resistance
2
2003
1167
0.120
 Why?
Hot Temperature
1
2017
370
0.110
 Why?
Interleukin-18
2
2006
237
0.110
 Why?
Peptides
1
2019
926
0.110
 Why?
Cross-Over Studies
4
2017
520
0.110
 Why?
Regression Analysis
5
2011
997
0.110
 Why?
Physical Education and Training
2
2024
75
0.110
 Why?
Interleukin-10
1
2015
300
0.100
 Why?
Hydrocortisone
1
2015
306
0.100
 Why?
Cholinergic Agonists
1
2011
6
0.090
 Why?
Injections, Intravenous
1
2012
202
0.090
 Why?
Blood Volume
4
1999
60
0.090
 Why?
Circadian Rhythm
1
2015
413
0.090
 Why?
Obesity, Abdominal
1
2011
47
0.090
 Why?
Waist Circumference
1
2011
138
0.090
 Why?
Hypoglycemic Agents
1
2019
1221
0.090
 Why?
Plaque, Atherosclerotic
1
2011
55
0.090
 Why?
Vital Capacity
2
2002
289
0.090
 Why?
Femoral Artery
2
2002
174
0.090
 Why?
Prevalence
3
2014
2564
0.090
 Why?
Apoptosis Regulatory Proteins
1
2011
182
0.090
 Why?
Plant Lectins
1
2010
8
0.080
 Why?
Staurosporine
1
2010
20
0.080
 Why?
Cholesterol
2
2005
412
0.080
 Why?
Estrogens
2
2003
347
0.080
 Why?
Aged, 80 and over
6
2003
7052
0.080
 Why?
Cerebrovascular Circulation
2
2023
228
0.080
 Why?
Granulocyte Colony-Stimulating Factor
1
2010
73
0.080
 Why?
Bone Diseases, Metabolic
1
2010
57
0.080
 Why?
Immunoenzyme Techniques
1
2009
212
0.080
 Why?
CD3 Complex
1
2009
102
0.080
 Why?
Cell Separation
1
2010
317
0.080
 Why?
Life Style
5
2003
461
0.080
 Why?
Leg
2
2001
239
0.080
 Why?
Phosphatidylinositol 3-Kinases
1
2011
361
0.080
 Why?
Proto-Oncogene Proteins c-akt
1
2011
432
0.080
 Why?
Norepinephrine
1
2009
210
0.080
 Why?
Up-Regulation
1
2012
840
0.080
 Why?
Endothelin-Converting Enzymes
1
2008
10
0.080
 Why?
Aspartic Acid Endopeptidases
1
2008
27
0.080
 Why?
Metalloendopeptidases
1
2008
59
0.070
 Why?
Methacholine Chloride
1
2008
52
0.070
 Why?
Cell Count
1
2008
312
0.070
 Why?
Calcium Channel Blockers
1
2008
161
0.070
 Why?
Hemiplegia
2
1997
21
0.070
 Why?
Arm
1
2007
107
0.070
 Why?
Coronary Circulation
1
2007
138
0.070
 Why?
Risk Assessment
1
2016
3262
0.070
 Why?
Probability
1
2007
306
0.060
 Why?
Lipoproteins, LDL
1
2006
127
0.060
 Why?
Microscopy, Phase-Contrast
1
2005
17
0.060
 Why?
Muscle, Skeletal
3
2002
1613
0.060
 Why?
Thymidine
1
2005
59
0.060
 Why?
DNA Methylation
1
2010
611
0.060
 Why?
Weight Loss
1
2010
738
0.060
 Why?
Bone Marrow Cells
1
2005
302
0.060
 Why?
Anaerobic Threshold
2
2005
28
0.060
 Why?
France
1
2024
29
0.060
 Why?
Hypocapnia
1
2023
8
0.050
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2008
430
0.050
 Why?
Thrombosis
1
2007
348
0.050
 Why?
Hyperventilation
1
2023
10
0.050
 Why?
History, 21st Century
1
2024
186
0.050
 Why?
Adenine
1
2005
258
0.050
 Why?
Compliance
4
2008
44
0.050
 Why?
Body Weight
2
2005
940
0.050
 Why?
History, 20th Century
1
2024
294
0.050
 Why?
Oxidation-Reduction
1
2006
1028
0.050
 Why?
Muscarinic Antagonists
1
2003
27
0.050
 Why?
Fenofibrate
1
2003
31
0.050
 Why?
Hypertriglyceridemia
1
2003
39
0.050
 Why?
Bicycling
1
2024
116
0.050
 Why?
Heart Rate
4
2001
802
0.050
 Why?
Sensitivity and Specificity
1
2007
1843
0.050
 Why?
Polymorphism, Genetic
1
2005
637
0.050
 Why?
Exercise Test
3
2005
613
0.050
 Why?
Carotid Artery Diseases
1
2002
64
0.050
 Why?
Progesterone
1
2003
245
0.050
 Why?
Universities
1
2024
409
0.050
 Why?
Adrenergic beta-Agonists
1
2002
133
0.050
 Why?
Carbon Dioxide
1
2023
259
0.050
 Why?
Tunica Intima
4
2002
84
0.050
 Why?
Systole
1
2001
191
0.040
 Why?
Ultrasonography
5
2002
712
0.040
 Why?
Heart Conduction System
1
2001
95
0.040
 Why?
Cardiovascular Physiological Phenomena
1
2000
41
0.040
 Why?
Knee
1
2000
63
0.040
 Why?
Mexican Americans
1
2001
113
0.040
 Why?
Predictive Value of Tests
1
2005
1947
0.040
 Why?
Hemorheology
1
2018
21
0.040
 Why?
Oxygen
1
2024
915
0.040
 Why?
Energy Intake
2
1998
462
0.040
 Why?
Body Constitution
1
1998
53
0.040
 Why?
Social Class
1
2001
259
0.040
 Why?
Drug Combinations
1
2019
331
0.040
 Why?
Diet, Fat-Restricted
1
2018
80
0.040
 Why?
Microvessels
1
2018
82
0.040
 Why?
Hemostasis
1
1998
80
0.040
 Why?
Plasminogen Activators
1
1997
7
0.030
 Why?
Cervical Vertebrae
1
2018
132
0.030
 Why?
Gait
2
1997
280
0.030
 Why?
United States
1
2014
13871
0.030
 Why?
Vascular Resistance
1
1998
371
0.030
 Why?
Cohort Studies
1
2007
5426
0.030
 Why?
Movement Disorders
1
1997
52
0.030
 Why?
Cerebrovascular Disorders
1
1997
90
0.030
 Why?
Chromium
1
1996
13
0.030
 Why?
Weight Lifting
1
1996
34
0.030
 Why?
Leukocytes, Mononuclear
1
2018
546
0.030
 Why?
Neoplasms
1
2010
2455
0.030
 Why?
Gene Expression Regulation
1
2025
2542
0.030
 Why?
Combined Modality Therapy
1
2017
1203
0.030
 Why?
Hypoxia
1
2021
1084
0.030
 Why?
Antigens
1
1996
356
0.030
 Why?
Melatonin
1
2015
125
0.030
 Why?
Swimming
3
1999
48
0.030
 Why?
Randomized Controlled Trials as Topic
1
2019
1365
0.030
 Why?
Menopause
1
1997
297
0.030
 Why?
Defibrillators, Implantable
1
1997
300
0.030
 Why?
Brain Ischemia
1
1997
321
0.030
 Why?
Tunica Media
2
2001
38
0.020
 Why?
Sex Factors
1
1996
1970
0.020
 Why?
Animals
3
2024
35391
0.020
 Why?
Brain
1
2020
2673
0.020
 Why?
Cardiac Output
2
1998
156
0.020
 Why?
Prospective Studies
4
2001
7135
0.020
 Why?
Bone Density
1
2010
463
0.020
 Why?
Stroke Volume
2
1998
592
0.020
 Why?
Hemostatics
1
2005
50
0.010
 Why?
Adolescent
5
2002
20412
0.010
 Why?
Hypolipidemic Agents
1
2003
92
0.010
 Why?
Fatty Acids, Nonesterified
1
2003
160
0.010
 Why?
Lipoproteins
1
2003
172
0.010
 Why?
Absorptiometry, Photon
1
2002
248
0.010
 Why?
Blood Viscosity
1
2001
16
0.010
 Why?
Habits
1
2001
44
0.010
 Why?
Thoracic Arteries
1
2000
4
0.010
 Why?
Thigh
1
2000
53
0.010
 Why?
Mexico
1
2001
191
0.010
 Why?
Thinness
1
2000
89
0.010
 Why?
Elasticity
1
2000
195
0.010
 Why?
Erythrocyte Volume
1
1999
6
0.010
 Why?
Plasma Volume
1
1999
19
0.010
 Why?
Femur
1
2001
243
0.010
 Why?
Stress, Mechanical
1
2001
467
0.010
 Why?
Supine Position
1
1998
38
0.010
 Why?
Posture
1
1999
175
0.010
 Why?
Signal Processing, Computer-Assisted
1
1998
144
0.010
 Why?
Hematocrit
1
1997
93
0.010
 Why?
Rest
1
1997
120
0.010
 Why?
Socioeconomic Factors
1
2001
1213
0.010
 Why?
Electric Conductivity
1
1997
94
0.010
 Why?
Ventricular Fibrillation
1
1997
57
0.010
 Why?
Electrodes, Implanted
1
1997
106
0.010
 Why?
Hyperlipidemias
1
1997
126
0.010
 Why?
Diabetes Complications
1
1997
224
0.010
 Why?
Equipment Design
1
1997
514
0.010
 Why?
Electrocardiography
1
1998
611
0.010
 Why?
Tachycardia, Ventricular
1
1997
168
0.010
 Why?
Multivariate Analysis
1
1998
1499
0.010
 Why?
Kinetics
1
1997
1645
0.010
 Why?
Stroke
1
2002
1071
0.010
 Why?
Heart Arrest
1
1997
320
0.010
 Why?
Survival Rate
1
1997
1872
0.010
 Why?
Length of Stay
1
1997
1122
0.010
 Why?
Energy Metabolism
1
1997
875
0.010
 Why?
Smoking
1
1997
1500
0.000
 Why?
Retrospective Studies
1
2003
14522
0.000
 Why?
DeSouza's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (402) concept(s)
_
Co-Authors Expand Description
See all (14) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)